服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-ERBB3/HER3 mAbs [Patritumab Biosimilar] (MABL-5073) | MABL-5073 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Pavurutamab Biosimilar] (MABL-5074) | MABL-5074 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-CD28 mAbs [Pegrizeprument Biosimilar] (MABL-5075) | MABL-5075 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FOLH1/GCPII/PSMA mAbs [Pelgifatamab Biosimilar] (MABL-5076) | MABL-5076 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47;DLL3 mAbs [Peluntamig Biosimilar] (MABL-5077) | MABL-5077 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Pembrolizumab Biosimilar] (MABL-5078) | MABL-5078 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Pemivibart Biosimilar] (MABL-5079) | MABL-5079 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CSF2 mAbs [Otilimab Biosimilar] (MABL-5047) | MABL-5047 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CD37 mAbs [Otlertuzumab Biosimilar] (MABL-5048) | MABL-5048 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL4R/CD124 mAbs [Oturkibart Biosimilar] (MABL-5049) | MABL-5049 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TNFSF4/CD134/CD252/OX40L mAbs [Oxelumab Biosimilar] (MABL-5050) | MABL-5050 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-RTN4/Nogo mAbs [Ozanezumab Biosimilar] (MABL-5051) | MABL-5051 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF10B/CD262/DR5/TRAILR2 mAbs [Ozekibart Biosimilar] (MABL-5052) | MABL-5052 | ELISA, FACS, Functional assay, in vivo binding | G1, na |
| Anti-TNF/TNFA;ALB mAbs [Ozoralizumab Biosimilar] (MABL-5053) | MABL-5053 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-IGHE mAbs [Ozureprubart Biosimilar] (MABL-5054) | MABL-5054 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ROR2 mAbs [Ozuriftamab Biosimilar] (MABL-5055) | MABL-5055 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TFRC/CD71 mAbs [Pabinafusp Biosimilar] (MABL-5056) | MABL-5056 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Pacanalotamab Biosimilar] (MABL-5057) | MABL-5057 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-IL6 mAbs [Pacibekitug Biosimilar] (MABL-5058) | MABL-5058 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-PDL1/CD274 mAbs [Pacmilimab Biosimilar] (MABL-5059) | MABL-5059 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn